Page 91 - 81_02
P. 91
170 @Real Academia Nacional de Farmacia. Spain ?%?Cell?viability?(MTT? b)?%?Cell?viability?(MTT? ?%?Cell?viability?(MTT? a)
reduction) 140?reduction) reduction) 140?
120? 120?
Control? 100?Control? Control? 100?
0.25? 0.25? 0.25?
0.5? 80?0.5? 0.5? 80?
1? 60?1? 1? 60?
2.5? 40?2.5? 2.5? 40?
5? 20?5? 5? 20?
10? 10? 10?
25? 0?25? 25? 0?
50? 50? 50?
100? c)100? 100?
Triton? 140?Triton? Triton?
120?
?%?Cell?viability?(MTT? 100??%?Cell?viability?(MTT? ?%?Cell?viability?(MTT?
reduction) 80? reduction) reduction)
60?
40?
20?
0?
(µg/mL)? (µg/mL)?
*** *
* **
*
(µg/mL)?
*
***
*
##
*
##
120?
100?
80?
60?
40?
20?
0?
120?
100?
80?
60?
40?
20?
0?
120?
100?
80?
60?
40?
20?
0?
(µg/mL)? (µg/mL)? + H2O2 (µg/mL)? Carlos Fernández-Moriano et al.
+ H2O2 + H2O2
#
